CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.
about
Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexusA novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environmentA novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS.HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection.Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulationAutophagy induction by histone deacetylase inhibitors inhibits HIV type 1.Human Immunodeficiency Virus Type 1 Nef Inhibits Autophagy through Transcription Factor EB SequestrationThe trinity of the cortical actin in the initiation of HIV-1 infectionInvolvement of LIM kinase 1 in actin polarization in human CD4 T cells.A dichotomy in cortical actin and chemotactic actin activity between human memory and naive T cells contributes to their differential susceptibility to HIV-1 infectionGenistein interferes with SDF-1- and HIV-mediated actin dynamics and inhibits HIV infection of resting CD4 T cells.Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.Novel anti-HIV therapeutics targeting chemokine receptors and actin regulatory pathwaysHIV-1 triggers WAVE2 phosphorylation in primary CD4 T cells and macrophages, mediating Arp2/3-dependent nuclear migration.Development and characterization of a human microglia cell model of HIV-1 infection.Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency.Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication.A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers
P2860
Q26991958-C03E6550-FE5D-461D-9BFD-81657354A31FQ28476693-4B644A08-1AE4-4CFF-9672-564B98F46675Q30495455-CBEE5B33-D399-4920-BEE6-1BEF2D584C02Q33581852-F5463439-7906-4C7E-8042-7E3AD4DC53CDQ34174790-6E8F1232-2BBC-408E-BA49-F1F854C2BFBDQ35041156-453510EA-DD50-4EA3-A530-F2D758B90046Q35103991-47BA5BD5-017E-4CDA-8433-09C325FED96BQ35675692-264AB889-CB3E-435C-91A0-D88CAC44957EQ36156531-079F5E7B-0234-4C1A-9CED-8D14E8837CD4Q36287278-E3829B66-472D-41FB-ADB2-BFCB44CD235AQ36318657-147DA0C1-EF73-4CE5-B32F-F140D2E09933Q36958453-145D39B2-257D-489E-97B0-A60EE305BBF3Q37150917-211699E9-E4F7-4CFB-9956-4CCDFAB726D7Q37466339-BF65FB06-F7CA-4102-9893-1E1A6F026397Q37622627-4AAFC425-8F96-492A-882E-6CF42D012643Q40570716-8374A221-FB33-4AB6-B4FC-2F1822C4AEA6Q45325496-C29E98BB-FC61-4397-8A34-1BCCFC87070CQ52687754-460DD4AE-B4B6-4B3B-8878-C3561B20FFF7Q57766050-625248DB-E369-4FA2-9F2D-1BF92FC23A60
P2860
CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.
@en
type
label
CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.
@en
prefLabel
CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.
@en
P2860
P356
P1476
CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells
@en
P2093
Stephen A Spector
P2860
P304
30745-30753
P356
10.1074/JBC.M804112200
P407
P577
2008-09-10T00:00:00Z